{
  "docId": "019de074-abc1-773c-9c2f-d49993e7b79a",
  "docSlug": "59a1ae16b5e60c748be3b046cd750424",
  "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 20 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4138439,
  "pageNumber": 16,
  "pageCount": 20,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "executive_summary",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Includes a quote from Stephen Fawell and a diagram illustrating epigenetic mechanisms (histone modification, DNA methylation, RNA interference).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-abc1-773c-9c2f-d49993e7b79a/16",
  "deckHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a",
  "deckJsonHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a.json",
  "deckAnchorHref": "/decks/019de074-abc1-773c-9c2f-d49993e7b79a#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.45,
        "y": 0.0045
      },
      "kind": "diagram",
      "text": "Biological diagram showing chromosome, histones, DNA methylation, and RNA interference.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "37b14745-7dd5-4a48-b2f2-f36c403d084a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.39,
        "y": 0.0017
      },
      "kind": "image",
      "text": "Stephen Fawell",
      "attrs": null,
      "subkind": "headshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "06568823-5bf1-48ff-bb82-546b993a4ef6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.05,
        "y": 0.49
      },
      "kind": "list",
      "text": "Our areas of focus include: Monitoring epigenetic changes, Understanding resistance mechanisms, Developing new ways to modulate gene expression, Exploiting synthetic lethality, Using epigenetics to reinvigorate immune response.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d911be38-2af9-4cb0-900c-7a2713637563",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.35,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "What is epigenetics? Building on decades of progress describing and targeting genetic changes identified in cancer, new technological advances have enabled a similar initiative for epigenetic biology.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "829768bb-6c20-40a2-bf6a-87da5484386b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.55,
        "y": 0.23
      },
      "kind": "quote",
      "text": "Epigenetics represents a relatively untapped opportunity in cancer biology for researchers, oncologists and tomorrow’s patients living with cancer.",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7251f23-7b82-4bcb-a434-eabd33d301a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.45,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Adapted from American Society of Hematology 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5681f0e-8f14-4cbc-a46a-58232a65888f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Overview and approach",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f975a79b-01f7-4ffc-bb84-c0eb94e24907",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "2e50b002-2618-479a-91c1-b9e474205203",
      "evidence": "The slide provides an overview of epigenetics and AstraZeneca's approach to targeting PRMT5.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 7,
      "beatId": "56cdd0e4-2e0f-4301-9ad2-c8da972ed7de",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "Details on novel treatments and pipeline advancements aim to satisfy the need with solutions.",
      "position": 3,
      "confidence": 0.7,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}